A versatile synthesis of (±)-deoxyfebrifugine, an antimalarial alkaloid analogue, and related compounds

Synlett

Volumn , Issue 3, 2006, Pages 383-386

  Michael, Joseph P ^a   De Koning, Charles B ^a   Pienaar, Daniel P ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Alkaloids; Enaminones; Heterocycles; Piperidines; Quinazolines

Indexed keywords

3 (3 BROMO 2 OXOPROPYL)QUINAZOLIN 4(3H) ONE; ALKALOID; ANTIMALARIAL AGENT; DEOXYFEBRIFUGINE; FEBRIFUGINE; HETEROCYCLIC COMPOUND; PIPERIDINE 2 THIONE; PIPERIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; QUININE; SULFIDE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CHINESE MEDICINE; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGENATION;

EID: 33344463287     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926233     Document Type: Article

References (50)

1. (a) Jang, C. S.; Fu, F. Y.; Wang, C. Y.; Huang, K. C.; Lu, G.; Chou, T. C. Science 1946, 103, 59.
2. (b) Koepfli, J. B.; Mead, J. F.; Brockman, J. A. Jr. J. Am. Chem. Soc. 1947, 69, 1837.
3. (c) Kuehl, F. A. Jr.; Spencer, C. F.; Folkers, K. J. Am. Chem. Soc. 1948, 70, 2091.
4. (d) Koepfli, J. B.; Mead, J. F.; Brockman, J. A. Jr. J. Am. Chem. Soc. 1949, 71, 1048.
5. (e) Koepfli, J. B.; Brockman, J. A. Jr.; Moffat, J. J. Am. Chem. Soc. 1950, 72, 3323.
6. (a) Ablondi, F.; Gordon, S.; Morton, J. II; Williams, J. H. J. Org. Chem. 1952, 17, 14.
7. (b) Hutchings, E. L.; Gordon, S.; Ablondi, F.; Wolf, C. F.; Williams, J. H. J. Org. Chem. 1952, 17, 19.
8. (c) Kato, M.; Inaba, M.; Itahana, H.; Ohara, E.; Nakamura, K.; Uesato, S.; Inouye, H.; Fujita, T. Shoyakugaku Zasshi 1990, 44, 288;
9. Chem. Abstr. 1991, 115, 64012f.
10. (d) Khalil, A. T.; Chang, F.-R.; Lee, Y.-H.; Chen, C.-Y.; Liaw, C.-C.; Ramesh, P.; Yuan, S.-S. F.; Wu, Y.-C. Arch. Pharm. Res. 2003, 26, 15.
11. Takeuchi, Y.; Harayama, T. Trends Heterocycl. Chem. 2001, 7, 65.
12. (a) Kobayashi, S.; Ueno, M.; Suzuki, R.; Ishitani, H. Tetrahedron Lett. 1999, 40, 2175.
13. (b) Kobayashi, S.; Ueno, M.; Suzuki, R.; Ishitani, H.; Kim, H.-S.; Wataya, Y. J. Org. Chem. 1999, 64, 6833.
14. (a) Murata, K.; Takano, F.; Fushiya, S.; Oshima, Y. J. Nat. Prod. 1998, 61, 729.
15. (b) Murata, K.; Takano, F.; Fushiya, S.; Oshima, Y. Biochem. Pharm. 1999, 58, 1593.
16. (a) Hirai, S.; Kikuchi, H.; Kim, H.-S.; Begum, K.; Wataya, Y.; Tasaka, H.; Miyazawa, Y.; Yamamoto, K.; Oshima, Y. J. Med. Chem. 2003, 46, 4351.
17. (b) Kikuchi, H.; Tasaka, H.; Hirai, S.; Takaya, Y.; Iwabuchi, Y.; Ooi, H.; Hatakeyama, S.; Kim, H.-S.; Wataya, Y.; Oshima, Y. J. Med. Chem. 2002, 45, 2563.
18. (c) Takeuchi, Y.; Koike, M.; Azuma, K.; Nishioka, H.; Abe, H.; Kim, H.-S.; Wataya, Y.; Harayama, T. Chem. Pharm. Bull. 2001, 49, 721.
19. (d) Takaya, Y.; Tasaka, H.; Chiba, T.; Uwai, K.; Tanitsu, M.; Kim, H.-S.; Wataya, Y.; Miura, M.; Takeshita, M.; Oshima, Y. J. Med. Chem. 1999, 42, 3163; and references cited therein.
20. Edeson, J. F. B.; Wilson, T. Trans. R. Soc. Trop. Med. Hyg. 1955, 49, 543.
21. For recent syntheses of optically active or racemic febrifugine, see the following: (a) Takeuchi, Y.; Oshige, M.; Azuma, K.; Abe, H.; Harayama, T. Chem. Pharm. Bull. 2005, 53, 868.
22. (b) Ashoorzadeh, A.; Caprio, V. Synlett 2005, 346.
23. (c) Katoh, M.; Matsune, R.; Nagase, H.; Honda, T. Tetrahedron Lett. 2004, 45, 6221.
24. (d) Huang, R-Q.; Wei, B.-G.; Ruan, Y.-P. Synlett 2003, 1663.
25. (e) Sugiura, M.; Hagio, H.; Hirabayashi, R.; Kobayashi, S. Synlett 2001, 1225.
26. (f) Ooi, H.; Urushibara, A.; Esumi, T.; Ibabuchi, Y.; Hatakeyama, S. Org. Lett. 2001, 3, 953.
27. (g) Sugiura, M.; Kobayashi, S. Org. Lett. 2001, 3, 477.
28. (h) Okitsu, O.; Suzuki, R.; Kobayashi, S. J. Org. Chem. 2001, 66, 809.
29. (i) Takeuchi, Y.; Azuma, K.; Takakura, K.; Abe, H.; Kim, H.-S.; Wataya, Y.; Harayama, T. Tetrahedron 2001, 57, 1213.
30. (j) For syntheses published prior to 2001, see the references cited in the preceding.
31. (a) Jiang, S.; Zeng, Q.; Gettayacamin, M.; Tungtaeng, A.; Wannaying, S.; Lim, A.; Hansukjariya, P.; Okunji, C. O.; Zhu, S.; Fang, D. Antimicrob. Agents Chemother. 2005, 49, 1169.
32. (b) Chien, P.-L.; Cheng, C. C. J. Med. Chem. 1970, 13, 867.
33. (c) Fishman, M.; Cruickshank, P. A. J. Med. Chem. 1970, 13, 155.
34. (d) Baker, B. R.; Schaub, R. E.; Joseph, J. P.; McEvoy, F. J.; Williams, J. H. J. Org. Chem. 1953, 18, 133; and references cited therein.
35. Takeuchi, Y.; Tokuda, S.; Takagi, T.; Koike, M.; Abe, H.; Harayama, T.; Shibata, Y.; Kim, H.-S.; Wataya, Y. Heterocycles 1999, 51, 1869.
36. Review: Michael, J. P.; de Koning, C. B.; Gravestock, D.; Hosken, G. D.; Howard, A. S.; Jungmann, C. M.; Krause, R. W. M.; Parsons, A. S.; Pelly, S. C.; Stanbury, T. V. Pure Appl. Chem. 1999, 71, 979.
37. Michael, J. P.; de Koning, C. B.; van der Westhuyzen, C. W. Org. Biomol. Chem. 2005, 3, 836; and references cited therein.
38. (a) Roth, M.; Dubs, P.; Götschi, E.; Eschenmoser, A. Helv. Chim. Acta 1971, 54, 710.
39. (b) Shiosaki, K. In Comprehensive Organic Synthesis, Vol. 2; Trost, B. M., Ed.; Pergamon Press: Oxford, 1991, 865-892.
40. von Niementowski, S. J. Prakt. Chem. 1895, 51, 564.
41. Weygand, F.; Schmied-Kowarzik, V. Chem. Ber. 1949, 82, 333.
42. Brillon, D. Synth. Commun. 1990, 20, 3085.
43. Honda, T.; Kimura, M. Org. Lett. 2000, 2, 3925.
44. Results of a more extensive crystallographic survey that includes 15 and representative examples of compounds 19 and 21 will be published elsewhere.
45. (a) Baker, B. R.; Querry, M. V.; Schaub, R. E.; Williams, J. H. J. Org. Chem. 1952, 17, 58.
46. (b) For an alternative synthesis of (±)-deoxyfebrifugine from the same group, see: Baker, B. R.; Querry, M. V.; Kadish, A. F.; Williams, J. H. J. Org. Chem. 1952, 17, 52.
47. Baker, B. R.; Schaub, R. E.; Querry, M. V.; Williams, J. H. J. Org. Chem. 1952, 17, 97.
48. Ghirlando, R.; Howard, A. S.; Katz, R. B.; Michael, J. P. Tetrahedron 1984, 40, 2879.
49. (a) Baker, B. R.; Schaub, R. E.; Williams, J. H. J. Org. Chem. 1952, 17, 109.
50. (b) Baker, B. R.; Schaub, R. E.; Williams, J. H. J. Org. Chem. 1952, 17, 116.